Blocking costimulatory signal for treating steroid-resistant asthma model

A. Mori, A. Abe, S. Kouyama, M. Yamaguchi, M. Enoki, Y. Iijima, C. Mitsui, C. Oshikata, H. Tanimoto, Y. Fukutomi, K. Sekiya, M. Taniguchi, Y. Maeda, M. Ohtomo, M. Hasegawa, K. Akiyama, T. Ohtomo, O. Kaminua (Sagamihara, Tokyo, Japan)

Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Session: Mechanisms and modulation of allergic inflammation in the lung
Session type: Thematic Poster Session
Number: 2321
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Mori, A. Abe, S. Kouyama, M. Yamaguchi, M. Enoki, Y. Iijima, C. Mitsui, C. Oshikata, H. Tanimoto, Y. Fukutomi, K. Sekiya, M. Taniguchi, Y. Maeda, M. Ohtomo, M. Hasegawa, K. Akiyama, T. Ohtomo, O. Kaminua (Sagamihara, Tokyo, Japan). Blocking costimulatory signal for treating steroid-resistant asthma model. Eur Respir J 2012; 40: Suppl. 56, 2321

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease
Source: Eur Respir J 2007; 30: 383-390
Year: 2007



IL-5/IL-13 drive NLRP3 inflammasome-mediated, steroid-resistant AHR in a model of obesity-associated asthma
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019

Analysis of cytokine signaling through the STAT6 activation in patients with atopic steroid-free asthma
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Year: 2007


T-cell co-stimulatory molecules: their role in allergic immune reactions
Source: Eur Respir J 2007; 29: 1246-1255
Year: 2007



Soluble CD40 ligand and soluble P-selectin in allergic asthma patients during exercise-induced bronchoconstriction
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Year: 2007


Plasma concentrations of costimulatory molecules are altered in children with chronic stable asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 616s
Year: 2005

Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011


TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Cellular mechanisms underlying steroid-resistant asthma
Source: Eur Respir Rev, 28 (153) 190096; 10.1183/16000617.0096-2019
Year: 2019



The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006


Characterisation of severe, steroid-dependent asthma patients who initiate biologics versus those who do not
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Expression of interleukin-4 receptor in bronchial asthma patients treated with specific immunotherapy (SIT)
Source: Eur Respir J 2002; 20: Suppl. 38, 589s
Year: 2002

Notch pathway signaling in asthma
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006


Interleukin-17 cytokine signalling in patients with asthma
Source: Eur Respir J 2014; 44: 1319-1331
Year: 2014



The immunological features of the severe steroid-resistant asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 479s
Year: 2003

CTLA4-Ig enhanced glucocorticoid effect on murine asthma
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017

Allergen specific immunotherapy induces T-cell anergy via upregulating CTLA-4 and downregulating CD86 in a murine OVA-sensitized model
Source: Eur Respir J 2004; 24: Suppl. 48, 349s
Year: 2004

MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease
Source: Eur Respir J 2007; 30: Suppl. 51, 60s
Year: 2007

The glucocorticoid nuclear action peculiarities in the steroid-resistant patients with severe bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 32s
Year: 2003